Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | 14.10 |
| peg ratio | -0.24 |
| price to book ratio | 4.53 |
| price to sales ratio | 7.18 |
| enterprise value multiple | 16.14 |
| price fair value | 4.53 |
profitability ratios | |
|---|---|
| gross profit margin | 99.21% |
| operating profit margin | 46.05% |
| pretax profit margin | 53.45% |
| net profit margin | 52.76% |
| return on assets | 28.29% |
| return on equity | 34.68% |
| return on capital employed | 26.66% |
liquidity ratio | |
|---|---|
| current ratio | 10.70 |
| quick ratio | 10.70 |
| cash ratio | 2.94 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 3.01 |
| days of payables outstanding | 437.45 |
| cash conversion cycle | -434.45 |
| receivables turnover | 121.32 |
| payables turnover | 0.83 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 64.94 |
| cash flow to debt ratio | 21.13 |
cash flow ratios | |
|---|---|
| free cash flow per share | 3.71 |
| cash per share | 7.59 |
| operating cash flow per share | 3.73 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 21.13 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 216.44 |
Frequently Asked Questions
Protagonist Therapeutics, Inc. (PTGX) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Protagonist Therapeutics, Inc. (NASDAQ:PTGX)'s trailing twelve months ROE is 34.68%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Protagonist Therapeutics, Inc. (PTGX) currently has a ROA of 28.29%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
PTGX reported a profit margin of 52.76% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.70 in the most recent quarter. The quick ratio stood at 10.70, with a Debt/Eq ratio of 0.02.